Companies:
49,739
Total Market Cap:
136065974976353.04
Global Rank
#781
Country Rank
#30
Market Cap
27.63 B
Price
49.06
Change (%)
0.73%
Volume
212,986
Fresenius SE & Co. KGaA's latest marketcap:
27.63 B
As of 06/26/2025, Fresenius SE & Co. KGaA's market capitalization has reached $27.63 B. According to our data, Fresenius SE & Co. KGaA is the 781th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 27.63 B |
| Revenue (ttm) | 25.88 B |
| Net Income (ttm) | 493.51 M |
| Shares Out | 563.24 M |
| EPS (ttm) | 0.88 |
| Forward PE | 12.44 |
| Ex-Dividend Date | 05/26/2025 |
| Earnings Date | 08/06/2025 |
Market Cap Chart
Data Updated: 06/26/2025
Fresenius SE & Co. KGaA's yearly market capitalization.
Fresenius SE & Co. KGaA has seen its market value grow from €23.37 B to €27.63 B since 2014, representing a total increase of 18.24% and an annual compound growth rate (CAGR) of 1.61%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | €27.63 B | 25.25% | 781 |
| 12/30/2024 | €18.89 B | 19.49% | 965 |
| 12/29/2023 | €15.81 B | 6.93% | 1009 |
| 12/30/2022 | €14.78 B | -25.21% | 1031 |
| 12/30/2021 | €19.77 B | -6.28% | 908 |
| 12/30/2020 | €21.09 B | -24.56% | 687 |
| 12/30/2019 | €27.96 B | 18.66% | 452 |
| 12/28/2018 | €23.57 B | -34.68% | 421 |
| 12/29/2017 | €36.08 B | -11.17% | 271 |
| 12/30/2016 | €40.62 B | 12.96% | 218 |
Company Profile
About Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA is a leading health care company specializing in products and services for chronically ill patients. Founded in 1912 and headquartered in Bad Homburg vor der Höhe, Germany, the company operates through four key segments.
Business Segments
- Fresenius Medical Care: Focuses on chronic kidney failure patients, offering dialyzers, dialysis machines, disposable products, and dialysis-related services.
- Fresenius Kabi: Provides critical care solutions, including enteral and parenteral nutrition products, medical technologies, infusion pumps, apheresis machines, and cell therapy devices.
- Fresenius Helios: Delivers clinical and nursing care through healthcare facilities.
- Fresenius Vamed: Offers hospital and healthcare facility management services, including operational oversight and patient care solutions.
Formerly known as Fresenius SE, the company rebranded as Fresenius SE & Co. KGaA in January 2011.
Frequently Asked Questions
-
What is Fresenius SE & Co. KGaA's (ETR-FRE) current market cap?As of 06/26/2025, Fresenius SE & Co. KGaA (including the parent company, if applicable) has an estimated market capitalization of $27.63 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Fresenius SE & Co. KGaA (ETR-FRE) rank globally by market cap?Fresenius SE & Co. KGaA global market capitalization ranking is approximately 781 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.